Zerodol Sp

What is Zerodol SP?

Zerodol SP is a fixed‑dose combination tablet that contains three active ingredients: aceclofenac (a non‑steroidal anti‑inflammatory drug, NSAID), paracetamol (acetaminophen) and serratiopeptidase (an enzyme with anti‑inflammatory properties). The blend is designed to provide rapid pain relief while reducing inflammation, making it popular for musculoskeletal and post‑operative pain.

How It Works

• Aceclofenac blocks cyclo‑oxygenase‑2 (COX‑2) enzymes, lowering prostaglandin synthesis and thus diminishing inflammation and pain.
• Paracetamol acts centrally to inhibit prostaglandin production in the brain, providing analgesia and antipyresis without significant peripheral anti‑inflammatory effects.
• Serratiopeptidase is a proteolytic enzyme that helps break down inflammatory exudates, potentially enhancing tissue healing and reducing swelling.

Approved Indications

• Osteoarthritis and rheumatoid arthritis
• Ankylosing spondylitis
• Acute low‑back pain
• Post‑operative pain (orthopedic, dental, or general surgery)
• Other inflammatory musculoskeletal conditions where NSAIDs are appropriate

Typical Dosage & Administration

• Adults: One tablet (10 mg aceclofenac + 325 mg paracetamol + 15 mg serratiopeptidase) twice daily, after meals, with a full glass of water.
• Missed Dose: Take the missed dose as soon as remembered unless the next scheduled dose is within 4 hours; in that case, skip the missed dose and continue the regular schedule.
• Maximum Daily Dose: Do not exceed two tablets per day (20 mg aceclofenac, 650 mg paracetamol, 30 mg serratiopeptidase).

Zerodol SP in Dental Infections – How It’s Used

• Purpose – Zerodol SP is not an antimicrobial; it is prescribed to control the pain and inflammation that accompany dental infections (e.g., acute apical periodontitis, pericoronitis, postoperative swelling after extractions or periodontal surgery).
• Typical Indication – Moderate‑to‑severe dental pain that is not adequately managed with paracetamol alone, especially when there is noticeable soft‑tissue inflammation or edema.
• Dosage for Dental Use –
  • Adults: 1 tablet (10 mg aceclofenac + 325 mg paracetamol + 15 mg serratiopeptidase) twice daily after meals.
  • Do not exceed 2 tablets per day; a 5‑day course is usually sufficient for acute dental pain.
• Advantages in Dentistry
  • Rapid analgesia from paracetamol combined with the anti‑inflammatory effect of aceclofenac.
  • Serratiopeptidase may help reduce postoperative facial swelling and promote faster resolution of inflammatory exudate.
  • Fixed‑dose combination simplifies prescribing and improves patient compliance compared with taking multiple separate pills.
• Safety Considerations Specific to Dental Patients
  • Gastro‑intestinal protection – Many dental patients are older or on NSAIDs for other conditions; consider a proton‑pump inhibitor (e.g., omeprazole 20 mg daily) if the patient has a history of ulcer disease.
  • Renal function – Verify adequate hydration, especially after oral surgery where fluid intake may be limited.
  • Bleeding risk – If the patient is on anticoagulants (warfarin, DOACs) or has recent extractions, monitor for prolonged bleeding; the NSAID component can impair platelet function.
  • Pregnancy – Avoid in the third trimester; use paracetamol alone if analgesia is needed.
• Drug Interactions Relevant to Dental Practice
  • Antibiotics – No direct interaction, but be aware that some patients may be on high‑dose metronidazole or clindamycin; monitor for GI upset.
  • Local anesthetics with epinephrine – No interaction, but the combined vasoconstrictive effect may increase blood pressure in hypertensive patients; keep an eye on vitals.
  • Analgesic stacking – Do not combine with additional NSAIDs (e.g., ibuprofen) or extra paracetamol‑containing products to stay within safe dosing limits.
• Patient Counseling Tips for Dental Cases
  • Take the tablet with food to minimize stomach irritation.
  • Avoid alcohol while on the medication to reduce liver stress from paracetamol.
  • If swelling does not improve after 48 hours or pain worsens, contact the dentist—this may signal a spreading infection that needs antibiotics or further intervention.
  • Report any signs of GI bleeding (black stools, vomiting blood) or unusual bruising promptly.

Key Safety Information

• Boxed Warning: No FDA boxed warning has been identified for Zerodol SP or its individual components.
• Major Risks:
  • Gastro‑intestinal (GI) irritation/ulceration – aceclofenac, like other NSAIDs, can cause dyspepsia, gastritis, peptic ulcers, or GI bleeding, especially in patients with a prior ulcer history.
  • Renal impairment – NSAIDs may reduce renal perfusion; caution in patients with chronic kidney disease or dehydration.
  • Cardiovascular events – NSAIDs carry a modest risk of myocardial infarction or stroke, particularly with long‑term use.
  • Hepatotoxicity – paracetamol overdose can cause severe liver injury; adhere strictly to the maximum daily dose.

• Contraindications (patients who should not take Zerodol SP):
  • Known hypersensitivity to aceclofenac, paracetamol, serratiopeptidase, or any excipients.
  • Active or recent (within 3 months) GI ulcer or bleeding.
  • Severe renal or hepatic insufficiency.
  • Uncontrolled hypertension or established cardiovascular disease where NSAIDs are contraindicated.
  • Pregnancy (third trimester) and lactation – NSAIDs may affect fetal circulation and ductus arteriosus; paracetamol is generally safer but the combination is not recommended.

• Drug Interactions to Watch
  • Anticoagulants/antiplatelets (e.g., warfarin, clopidogrel) – increased bleeding risk.
  • Other NSAIDs or COX‑2 inhibitors – additive GI and renal toxicity.
  • Lithium – NSAIDs may raise serum lithium levels.
  • Methotrexate – reduced renal clearance may increase toxicity.
  • Selective serotonin reuptake inhibitors (SSRIs)

Patient Counseling Tips

• Take tablets with food to lessen stomach upset.
• Avoid alcohol while on this medication to reduce liver stress.
• Do not exceed the prescribed dose; accidental double‑dosing is a common cause of paracetamol toxicity.
• Report any signs of GI bleeding (black stools, vomiting blood) or unexplained swelling promptly.
• Keep the medication out of reach of children.

Summary

Zerodol SP offers a convenient triple‑action approach for acute and chronic inflammatory pain. Its efficacy stems from the synergistic effects of an NSAID, a central analgesic, and an anti‑inflammatory enzyme. While generally well‑tolerated, clinicians must remain vigilant about GI, renal, hepatic, and cardiovascular risks, especially in vulnerable populations. Proper patient education and adherence to dosing guidelines are essential to maximize benefit and minimize harm.

—

Quick Reference

• Dose: 1 tablet BID after meals (max 2 tablets/day).
• Avoid: Active GI ulcer, severe renal/hepatic disease, third‑trimester pregnancy.
• Key Risks: GI bleeding, renal impairment, hepatotoxicity (paracetamol).
• Interactions: Anticoagulants, other NSAIDs, lithium, methotrexate, SSRIs.
• Monitoring: Look for GI symptoms, renal function, liver enzymes in high‑risk patients.

Clinical Pearls

• Gastro‑protection: Co‑prescribe a proton‑pump inhibitor for patients with prior ulcer disease or those on chronic therapy.
• Renal safety: Ensure adequate hydration and avoid concurrent nephrotoxic drugs.
• Paracetamol ceiling: Never exceed 4 g of paracetamol per day from all sources; consider total daily intake when patients use other acetaminophen‑containing products.
• Enzyme benefit: Serratiopeptidase may reduce postoperative swelling faster than NSAID alone—useful in oral surgery cases.
• Patient adherence: The twice‑daily schedule aligns well with typical meal times, improving compliance

FAQ